BDBM528240 US11180494, Example 110::US11180494, Example 111

SMILES OC(=O)C(CCO[C@H]1C[C@H](CCc2ccc3CCCNc3n2)C1)NC(=O)C1CCc2ccccc12

InChI Key InChIKey=OZIYQSDCYIZVEA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 528240   

TargetIntegrin alpha-V/beta-6(Human)
Pliant Therapeutics

US Patent
LigandPNGBDBM528240(US11180494, Example 111 | US11180494, Example 110)
Affinity DataIC50: 150nMAssay Description:The biochemical potency of compounds was determined using a proximity-based assay (ALPHASCREEN , Perkin Elmer, Waltham, Mass.) as described previousl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-V/beta-6(Human)
Pliant Therapeutics

US Patent
LigandPNGBDBM528240(US11180494, Example 111 | US11180494, Example 110)
Affinity DataIC50: 50nMAssay Description:The biochemical potency of compounds was determined using a proximity-based assay (ALPHASCREEN , Perkin Elmer, Waltham, Mass.) as described previousl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent